Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urologic Neoplasms × Neostigmine × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1

Interventions

Gemcitabine 7 pembrolizumab 4 atezolizumab 3 Trastuzumab 3 Sunitinib 3 Carboplatin 3 enfortumab vedotin 2 dodecyl maltoside 2 cabozantinib 2 Water 2 Standard of Care 2 Pemetrexed 2 Paclitaxel 2 Cisplatin 2 Cetuximab 2 Bevacizumab 2 vinflunine 1 valrubicin 1 tislelizumab 1 testosterone 17 beta-cypionate 1 temsirolimus 1 poly ICLC 1 niraparib 1 montanide ISA 51 1 lenvatinib 1 flt3 ligand protein 1 delta 24-sterol reductase 1 daratumumab 1 avelumab 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03210376 2020-11-25

Neuromuscular Blockade on Shoulder Pain of Elderly

M.D. Anderson Cancer Center

Phase 4 Completed

100 enrolled 17 charts

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡